These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 18302537)
1. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture. Krampe B; Swiderek H; Al-Rubeai M Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537 [TBL] [Abstract][Full Text] [Related]
2. Functional genome-wide analysis of antibody producing NS0 cell line cultivated at different temperatures. Swiderek H; Al-Rubeai M Biotechnol Bioeng; 2007 Oct; 98(3):616-30. PubMed ID: 17421047 [TBL] [Abstract][Full Text] [Related]
3. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627 [TBL] [Abstract][Full Text] [Related]
4. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line. Wu MH; Dimopoulos G; Mantalaris A; Varley J Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706 [TBL] [Abstract][Full Text] [Related]
5. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions. Ho Y; Varley J; Mantalaris A Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302 [TBL] [Abstract][Full Text] [Related]
6. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture. Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445 [TBL] [Abstract][Full Text] [Related]
7. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines. Khoo SH; Falciani F; Al-Rubeai M Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793 [TBL] [Abstract][Full Text] [Related]
8. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis. Browne SM; Al-Rubeai M Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261 [TBL] [Abstract][Full Text] [Related]
9. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells. Ibarra N; Watanabe S; Bi JX; Shuttleworth J; Al-Rubeai M Biotechnol Prog; 2003; 19(1):224-8. PubMed ID: 12573029 [TBL] [Abstract][Full Text] [Related]
10. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis. Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534 [TBL] [Abstract][Full Text] [Related]
11. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis. Veraitch FS; Al-Rubeai M Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848 [TBL] [Abstract][Full Text] [Related]
12. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors. Spens E; Häggström L Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244 [TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Alete DE; Racher AJ; Birch JR; Stansfield SH; James DC; Smales CM Proteomics; 2005 Dec; 5(18):4689-704. PubMed ID: 16247733 [TBL] [Abstract][Full Text] [Related]
14. Large-scale gene expression analysis of cholesterol dependence in NS0 cells. Seth G; Philp RJ; Denoya CD; McGrath K; Stutzman-Engwall KJ; Yap M; Hu WS Biotechnol Bioeng; 2005 Jun; 90(5):552-67. PubMed ID: 15830340 [TBL] [Abstract][Full Text] [Related]
15. Molecular portrait of high productivity in recombinant NS0 cells. Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768 [TBL] [Abstract][Full Text] [Related]
16. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity. Tey BT; Al-Rubeai M Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426 [TBL] [Abstract][Full Text] [Related]
17. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture. Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors. Okonkowski J; Balasubramanian U; Seamans C; Fries S; Zhang J; Salmon P; Robinson D; Chartrain M J Biosci Bioeng; 2007 Jan; 103(1):50-9. PubMed ID: 17298901 [TBL] [Abstract][Full Text] [Related]
19. Hyperosmotic stress in murine hybridoma cells: effects on antibody transcription, translation, posttranslational processing, and the cell cycle. Sun Z; Zhou R; Liang S; McNeeley KM; Sharfstein ST Biotechnol Prog; 2004; 20(2):576-89. PubMed ID: 15059005 [TBL] [Abstract][Full Text] [Related]
20. Global expression profiling of Bacillus subtilis cells during industrial-close fed-batch fermentations with different nitrogen sources. Jürgen B; Tobisch S; Wümpelmann M; Gördes D; Koch A; Thurow K; Albrecht D; Hecker M; Schweder T Biotechnol Bioeng; 2005 Nov; 92(3):277-98. PubMed ID: 16178035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]